Visual cortex repetitive transcranial magnetic stimulation (rTMS) reversing neurodevelopmental impairments in adolescents with major psychiatric disorders (MPDs): A cross-species translational study.

Authors:
Liu J; Guo H; Yang J; Xiao Y; Cai A and 8 more

Journal:
CNS Neurosci Ther

Publication Year: 2023

DOI:
10.1111/cns.14427

PMCID:
PMC10915985

PMID:
37721197

Journal Information

Full Title: CNS Neurosci Ther

Abbreviation: CNS Neurosci Ther

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Therapeutics

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
5/6
83.3% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"data s1."

Code Sharing
Evidence found in paper:

"CONFLICT OF INTEREST STATEMENT The authors declare no biomedical financial interests or potential conflicts of interest."

Evidence found in paper:

"FUNDING INFORMATION This work was supported by the National Science Fund for Distinguished Young Scholars to FW (Grant No. 81725005); National Natural Science Foundation Regional Innovation and Development Joint Fund to FW (Grant No. U20A6005); Jiangsu Provincial Key Research and Development Program to FW (Grant No. BE2021617); National Natural Science Foundation of China to RZ (Grant No. 82151315); Jiangsu Provincial Key Research and Development Program to RZ (Grant No. BE2022160); Key Project supported by Medical Science and Technology Development Foundation, Jiangsu Commission of Health to RZ (Grant No. ZD2021026); and National Natural Science Foundation of China to XZ (Grant No. 62176129)."

Evidence found in paper:

"In the second prospective cohort, 21 adolescents with MPDs received 10 sessions of rTMS intervention using the visual cortex as the stimulation site. Clinical symptoms were assessed and fMRI data were collected before and after rTMS. Written informed consent was obtained from all participants and their parents. The trial was approved by the Ethics Committee of the Affiliated Nanjing Brain Hospital of Nanjing Medical University and registered in the Chinese Clinical Trial Registry (ChiCTR2100045391)."

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025